Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer

Eur J Cancer. 1995 Dec;31A(13-14):2424-6. doi: 10.1016/0959-8049(95)00403-3.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carcinoma, Small Cell / drug therapy*
  • Carmustine / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Epirubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged

Substances

  • Granulocyte Colony-Stimulating Factor
  • Epirubicin
  • Etoposide
  • Cyclophosphamide
  • Carboplatin
  • Carmustine

Supplementary concepts

  • CBV protocol